However, HTLV-1 seems to take advantage of its high susceptibility to the host antiviral system, specifically ZAP-mediated viral RNA processing, to minimize viral antigen expression and thereby maintain latent infection. This evidence concerns the gene ZC3HAV1 and disease arising from reactivation of latent virus.